Global Stereotactic-guided Biopsy Instrument Market Research Report 2023

The global Stereotactic-guided Biopsy Instrument market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Stereotactic-guided Biopsy Instrument is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Stereotactic-guided Biopsy Instrument is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Stereotactic-guided Biopsy Instrument include C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan) and Boston Scientific Corporation (U.S.), etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Stereotactic-guided Biopsy Instrument, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stereotactic-guided Biopsy Instrument.

The Stereotactic-guided Biopsy Instrument market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Stereotactic-guided Biopsy Instrument market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Stereotactic-guided Biopsy Instrument manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Stereotactic-guided Biopsy Instrument

1.2 Stereotactic-guided Biopsy Instrument Segment by Type

1.2.1 Global Stereotactic-guided Biopsy Instrument Market Value Comparison by Type (2023-2029)

1.2.2 Needle-based Biopsy Instruments

1.2.3 Localization Wires

1.2.4 Procedure Trays

1.2.5 Others

1.3 Stereotactic-guided Biopsy Instrument Segment by Application

1.3.1 Global Stereotactic-guided Biopsy Instrument Market Value by Application: (2023-2029)

1.3.2 Breast Biopsy

1.3.3 Lung Biopsy

1.3.4 Colorectal Biopsy

1.3.5 Prostate Biopsy

1.3.6 Others

1.4 Global Stereotactic-guided Biopsy Instrument Market Size Estimates and Forecasts

1.4.1 Global Stereotactic-guided Biopsy Instrument Revenue 2018-2029

1.4.2 Global Stereotactic-guided Biopsy Instrument Sales 2018-2029

1.4.3 Global Stereotactic-guided Biopsy Instrument Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Manufacturers (2018-2023)

2.2 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Stereotactic-guided Biopsy Instrument Average Price by Manufacturers (2018-2023)

2.4 Global Stereotactic-guided Biopsy Instrument Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Stereotactic-guided Biopsy Instrument, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Stereotactic-guided Biopsy Instrument, Product Type & Application

2.7 Stereotactic-guided Biopsy Instrument Market Competitive Situation and Trends

2.7.1 Stereotactic-guided Biopsy Instrument Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Stereotactic-guided Biopsy Instrument Players Market Share by Revenue

2.7.3 Global Stereotactic-guided Biopsy Instrument Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Stereotactic-guided Biopsy Instrument Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Stereotactic-guided Biopsy Instrument Global Stereotactic-guided Biopsy Instrument Sales by Region: 2018-2029

3.2.1 Global Stereotactic-guided Biopsy Instrument Sales by Region: 2018-2023

3.2.2 Global Stereotactic-guided Biopsy Instrument Sales by Region: 2024-2029

3.3 Global Stereotactic-guided Biopsy Instrument Global Stereotactic-guided Biopsy Instrument Revenue by Region: 2018-2029

3.3.1 Global Stereotactic-guided Biopsy Instrument Revenue by Region: 2018-2023

3.3.2 Global Stereotactic-guided Biopsy Instrument Revenue by Region: 2024-2029

3.4 North America Stereotactic-guided Biopsy Instrument Market Facts & Figures by Country

3.4.1 North America Stereotactic-guided Biopsy Instrument Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Stereotactic-guided Biopsy Instrument Sales by Country (2018-2029)

3.4.3 North America Stereotactic-guided Biopsy Instrument Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Stereotactic-guided Biopsy Instrument Market Facts & Figures by Country

3.5.1 Europe Stereotactic-guided Biopsy Instrument Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Stereotactic-guided Biopsy Instrument Sales by Country (2018-2029)

3.5.3 Europe Stereotactic-guided Biopsy Instrument Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Stereotactic-guided Biopsy Instrument Market Facts & Figures by Country

3.6.1 Asia Pacific Stereotactic-guided Biopsy Instrument Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Country (2018-2029)

3.6.3 Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Stereotactic-guided Biopsy Instrument Market Facts & Figures by Country

3.7.1 Latin America Stereotactic-guided Biopsy Instrument Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Stereotactic-guided Biopsy Instrument Sales by Country (2018-2029)

3.7.3 Latin America Stereotactic-guided Biopsy Instrument Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Stereotactic-guided Biopsy Instrument Market Facts & Figures by Country

3.8.1 Middle East and Africa Stereotactic-guided Biopsy Instrument Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Stereotactic-guided Biopsy Instrument Sales by Country (2018-2029)

3.8.3 Middle East and Africa Stereotactic-guided Biopsy Instrument Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Stereotactic-guided Biopsy Instrument Sales by Type (2018-2029)

4.1.1 Global Stereotactic-guided Biopsy Instrument Sales by Type (2018-2023)

4.1.2 Global Stereotactic-guided Biopsy Instrument Sales by Type (2024-2029)

4.1.3 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2018-2029)

4.2 Global Stereotactic-guided Biopsy Instrument Revenue by Type (2018-2029)

4.2.1 Global Stereotactic-guided Biopsy Instrument Revenue by Type (2018-2023)

4.2.2 Global Stereotactic-guided Biopsy Instrument Revenue by Type (2024-2029)

4.2.3 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Type (2018-2029)

4.3 Global Stereotactic-guided Biopsy Instrument Price by Type (2018-2029)

5.1 Global Stereotactic-guided Biopsy Instrument Sales by Application (2018-2029)

5.1.1 Global Stereotactic-guided Biopsy Instrument Sales by Application (2018-2023)

5.1.2 Global Stereotactic-guided Biopsy Instrument Sales by Application (2024-2029)

5.1.3 Global Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2018-2029)

5.2 Global Stereotactic-guided Biopsy Instrument Revenue by Application (2018-2029)

5.2.1 Global Stereotactic-guided Biopsy Instrument Revenue by Application (2018-2023)

5.2.2 Global Stereotactic-guided Biopsy Instrument Revenue by Application (2024-2029)

5.2.3 Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Application (2018-2029)

5.3 Global Stereotactic-guided Biopsy Instrument Price by Application (2018-2029)

6.1 C. R. Bard, Inc. (U.S.)

6.1.1 C. R. Bard, Inc. (U.S.) Corporation Information

6.1.2 C. R. Bard, Inc. (U.S.) Description and Business Overview

6.1.3 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2018-2023)

6.1.4 C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio

6.1.5 C. R. Bard, Inc. (U.S.) Recent Developments/Updates

6.2 Becton, Dickinson and Company (U.S.)

6.2.1 Becton, Dickinson and Company (U.S.) Corporation Information

6.2.2 Becton, Dickinson and Company (U.S.) Description and Business Overview

6.2.3 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio

6.2.5 Becton, Dickinson and Company (U.S.) Recent Developments/Updates

6.3 Cook Group Incorporated (U.S.)

6.3.1 Cook Group Incorporated (U.S.) Corporation Information

6.3.2 Cook Group Incorporated (U.S.) Description and Business Overview

6.3.3 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio

6.3.5 Cook Group Incorporated (U.S.) Recent Developments/Updates

6.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany)

6.4.1 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Corporation Information

6.4.2 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Description and Business Overview

6.4.3 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Product Portfolio

6.4.5 Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Recent Developments/Updates

6.5 Argon Medical Devices (U.S.)

6.5.1 Argon Medical Devices (U.S.) Corporation Information

6.5.2 Argon Medical Devices (U.S.) Description and Business Overview

6.5.3 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio

6.5.5 Argon Medical Devices (U.S.) Recent Developments/Updates

6.6 B. Braun Melsungen AG (Germany)

6.6.1 B. Braun Melsungen AG (Germany) Corporation Information

6.6.2 B. Braun Melsungen AG (Germany) Description and Business Overview

6.6.3 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2018-2023)

6.6.4 B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Product Portfolio

6.6.5 B. Braun Melsungen AG (Germany) Recent Developments/Updates

6.7 Cardinal Health, Inc. (U.S.)

6.6.1 Cardinal Health, Inc. (U.S.) Corporation Information

6.6.2 Cardinal Health, Inc. (U.S.) Description and Business Overview

6.6.3 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio

6.7.5 Cardinal Health, Inc. (U.S.) Recent Developments/Updates

6.8 Olympus Corporation (Japan)

6.8.1 Olympus Corporation (Japan) Corporation Information

6.8.2 Olympus Corporation (Japan) Description and Business Overview

6.8.3 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Product Portfolio

6.8.5 Olympus Corporation (Japan) Recent Developments/Updates

6.9 Boston Scientific Corporation (U.S.)

6.9.1 Boston Scientific Corporation (U.S.) Corporation Information

6.9.2 Boston Scientific Corporation (U.S.) Description and Business Overview

6.9.3 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio

6.9.5 Boston Scientific Corporation (U.S.) Recent Developments/Updates

6.10 FUJIFILM Holdings Corporation (Japan)

6.10.1 FUJIFILM Holdings Corporation (Japan) Corporation Information

6.10.2 FUJIFILM Holdings Corporation (Japan) Description and Business Overview

6.10.3 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2018-2023)

6.10.4 FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Product Portfolio

6.10.5 FUJIFILM Holdings Corporation (Japan) Recent Developments/Updates

6.11 INRAD, Inc. (U.S.)

6.11.1 INRAD, Inc. (U.S.) Corporation Information

6.11.2 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Description and Business Overview

6.11.3 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2018-2023)

6.11.4 INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product Portfolio

6.11.5 INRAD, Inc. (U.S.) Recent Developments/Updates

6.12 Medtronic plc (Ireland)

6.12.1 Medtronic plc (Ireland) Corporation Information

6.12.2 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Description and Business Overview

6.12.3 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Product Portfolio

6.12.5 Medtronic plc (Ireland) Recent Developments/Updates

7.1 Stereotactic-guided Biopsy Instrument Industry Chain Analysis

7.2 Stereotactic-guided Biopsy Instrument Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Stereotactic-guided Biopsy Instrument Production Mode & Process

7.4 Stereotactic-guided Biopsy Instrument Sales and Marketing

7.4.1 Stereotactic-guided Biopsy Instrument Sales Channels

7.4.2 Stereotactic-guided Biopsy Instrument Distributors

7.5 Stereotactic-guided Biopsy Instrument Customers

8.1 Stereotactic-guided Biopsy Instrument Industry Trends

8.2 Stereotactic-guided Biopsy Instrument Market Drivers

8.3 Stereotactic-guided Biopsy Instrument Market Challenges

8.4 Stereotactic-guided Biopsy Instrument Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Stereotactic-guided Biopsy Instrument Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Stereotactic-guided Biopsy Instrument Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Stereotactic-guided Biopsy Instrument Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Stereotactic-guided Biopsy Instrument Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Stereotactic-guided Biopsy Instrument Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Stereotactic-guided Biopsy Instrument Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Stereotactic-guided Biopsy Instrument Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Stereotactic-guided Biopsy Instrument, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Stereotactic-guided Biopsy Instrument, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Stereotactic-guided Biopsy Instrument, Product Type & Application

    Table 12. Global Key Manufacturers of Stereotactic-guided Biopsy Instrument, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Stereotactic-guided Biopsy Instrument by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stereotactic-guided Biopsy Instrument as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Stereotactic-guided Biopsy Instrument Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Stereotactic-guided Biopsy Instrument Sales by Region (2018-2023) & (K Units)

    Table 18. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Region (2018-2023)

    Table 19. Global Stereotactic-guided Biopsy Instrument Sales by Region (2024-2029) & (K Units)

    Table 20. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Region (2024-2029)

    Table 21. Global Stereotactic-guided Biopsy Instrument Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Region (2018-2023)

    Table 23. Global Stereotactic-guided Biopsy Instrument Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Region (2024-2029)

    Table 25. North America Stereotactic-guided Biopsy Instrument Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Stereotactic-guided Biopsy Instrument Sales by Country (2018-2023) & (K Units)

    Table 27. North America Stereotactic-guided Biopsy Instrument Sales by Country (2024-2029) & (K Units)

    Table 28. North America Stereotactic-guided Biopsy Instrument Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Stereotactic-guided Biopsy Instrument Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Stereotactic-guided Biopsy Instrument Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Stereotactic-guided Biopsy Instrument Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Stereotactic-guided Biopsy Instrument Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Stereotactic-guided Biopsy Instrument Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Stereotactic-guided Biopsy Instrument Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Stereotactic-guided Biopsy Instrument Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Stereotactic-guided Biopsy Instrument Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Stereotactic-guided Biopsy Instrument Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Stereotactic-guided Biopsy Instrument Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Stereotactic-guided Biopsy Instrument Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Stereotactic-guided Biopsy Instrument Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Stereotactic-guided Biopsy Instrument Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Stereotactic-guided Biopsy Instrument Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Stereotactic-guided Biopsy Instrument Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Stereotactic-guided Biopsy Instrument Sales (K Units) by Type (2018-2023)

    Table 51. Global Stereotactic-guided Biopsy Instrument Sales (K Units) by Type (2024-2029)

    Table 52. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2018-2023)

    Table 53. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Type (2024-2029)

    Table 54. Global Stereotactic-guided Biopsy Instrument Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Stereotactic-guided Biopsy Instrument Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Type (2018-2023)

    Table 57. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Type (2024-2029)

    Table 58. Global Stereotactic-guided Biopsy Instrument Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Stereotactic-guided Biopsy Instrument Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Stereotactic-guided Biopsy Instrument Sales (K Units) by Application (2018-2023)

    Table 61. Global Stereotactic-guided Biopsy Instrument Sales (K Units) by Application (2024-2029)

    Table 62. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2018-2023)

    Table 63. Global Stereotactic-guided Biopsy Instrument Sales Market Share by Application (2024-2029)

    Table 64. Global Stereotactic-guided Biopsy Instrument Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Stereotactic-guided Biopsy Instrument Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Application (2018-2023)

    Table 67. Global Stereotactic-guided Biopsy Instrument Revenue Market Share by Application (2024-2029)

    Table 68. Global Stereotactic-guided Biopsy Instrument Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Stereotactic-guided Biopsy Instrument Price (USD/Unit) by Application (2024-2029)

    Table 70. C. R. Bard, Inc. (U.S.) Corporation Information

    Table 71. C. R. Bard, Inc. (U.S.) Description and Business Overview

    Table 72. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. C. R. Bard, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product

    Table 74. C. R. Bard, Inc. (U.S.) Recent Developments/Updates

    Table 75. Becton, Dickinson and Company (U.S.) Corporation Information

    Table 76. Becton, Dickinson and Company (U.S.) Description and Business Overview

    Table 77. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Becton, Dickinson and Company (U.S.) Stereotactic-guided Biopsy Instrument Product

    Table 79. Becton, Dickinson and Company (U.S.) Recent Developments/Updates

    Table 80. Cook Group Incorporated (U.S.) Corporation Information

    Table 81. Cook Group Incorporated (U.S.) Description and Business Overview

    Table 82. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Cook Group Incorporated (U.S.) Stereotactic-guided Biopsy Instrument Product

    Table 84. Cook Group Incorporated (U.S.) Recent Developments/Updates

    Table 85. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Corporation Information

    Table 86. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Description and Business Overview

    Table 87. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Stereotactic-guided Biopsy Instrument Product

    Table 89. Devicor Medical Products, Inc., (Leica Biosystems) (Germany) Recent Developments/Updates

    Table 90. Argon Medical Devices (U.S.) Corporation Information

    Table 91. Argon Medical Devices (U.S.) Description and Business Overview

    Table 92. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Argon Medical Devices (U.S.) Stereotactic-guided Biopsy Instrument Product

    Table 94. Argon Medical Devices (U.S.) Recent Developments/Updates

    Table 95. B. Braun Melsungen AG (Germany) Corporation Information

    Table 96. B. Braun Melsungen AG (Germany) Description and Business Overview

    Table 97. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. B. Braun Melsungen AG (Germany) Stereotactic-guided Biopsy Instrument Product

    Table 99. B. Braun Melsungen AG (Germany) Recent Developments/Updates

    Table 100. Cardinal Health, Inc. (U.S.) Corporation Information

    Table 101. Cardinal Health, Inc. (U.S.) Description and Business Overview

    Table 102. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. Cardinal Health, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product

    Table 104. Cardinal Health, Inc. (U.S.) Recent Developments/Updates

    Table 105. Olympus Corporation (Japan) Corporation Information

    Table 106. Olympus Corporation (Japan) Description and Business Overview

    Table 107. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. Olympus Corporation (Japan) Stereotactic-guided Biopsy Instrument Product

    Table 109. Olympus Corporation (Japan) Recent Developments/Updates

    Table 110. Boston Scientific Corporation (U.S.) Corporation Information

    Table 111. Boston Scientific Corporation (U.S.) Description and Business Overview

    Table 112. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. Boston Scientific Corporation (U.S.) Stereotactic-guided Biopsy Instrument Product

    Table 114. Boston Scientific Corporation (U.S.) Recent Developments/Updates

    Table 115. FUJIFILM Holdings Corporation (Japan) Corporation Information

    Table 116. FUJIFILM Holdings Corporation (Japan) Description and Business Overview

    Table 117. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 118. FUJIFILM Holdings Corporation (Japan) Stereotactic-guided Biopsy Instrument Product

    Table 119. FUJIFILM Holdings Corporation (Japan) Recent Developments/Updates

    Table 120. INRAD, Inc. (U.S.) Corporation Information

    Table 121. INRAD, Inc. (U.S.) Description and Business Overview

    Table 122. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 123. INRAD, Inc. (U.S.) Stereotactic-guided Biopsy Instrument Product

    Table 124. INRAD, Inc. (U.S.) Recent Developments/Updates

    Table 125. Medtronic plc (Ireland) Corporation Information

    Table 126. Medtronic plc (Ireland) Description and Business Overview

    Table 127. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 128. Medtronic plc (Ireland) Stereotactic-guided Biopsy Instrument Product

    Table 129. Medtronic plc (Ireland) Recent Developments/Updates

    Table 130. Key Raw Materials Lists

    Table 131. Raw Materials Key Suppliers Lists

    Table 132. Stereotactic-guided Biopsy Instrument Distributors List

    Table 133. Stereotactic-guided Biopsy Instrument Customers List

    Table 134. Stereotactic-guided Biopsy Instrument Market Trends

    Table 135. Stereotactic-guided Biopsy Instrument Market Drivers

    Table 136. Stereotactic-guided Biopsy Instrument Market Challenges

    Table 137. Stereotactic-guided Biopsy Instrument Market Restraints

    Table 138. Research Programs/Design for This Report

    Table 139. Key Data Information from Secondary Sources

    Table 140. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Stereotactic-guided Biopsy Instrument

    Figure 2. Global Stereotactic-guided Biopsy Instrument Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Stereotactic-guided Biopsy Instrument Market Share by Type in 2022 & 2029

    Figure 4. Needle-based Biopsy Instruments Product Picture

    Figure 5. Localization Wires Product Picture

    Figure 6. Procedure Trays Product Picture

    Figure 7. Others Product Picture

    Figure 8. Global Stereotactic-guided Biopsy Instrument Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Stereotactic-guided Biopsy Instrument Market Share by Application in 2022 & 2029

    Figure 10. Breast Biopsy

    Figure 11. Lung Biopsy

    Figure 12. Colorectal Biopsy

    Figure 13. Prostate Biopsy

    Figure 14. Others

    Figure 15. Global Stereotactic-guided Biopsy Instrument Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Stereotactic-guided Biopsy Instrument Market Size (2018-2029) & (US$ Million)

    Figure 17. Global Stereotactic-guided Biopsy Instrument Sales (2018-2029) & (K Units)

    Figure 18. Global Stereotactic-guided Biopsy Instrument Average Price (USD/Unit) & (2018-2029)

    Figure 19. Stereotactic-guided Biopsy Instrument Report Years Considered

    Figure 20. Stereotactic-guided Biopsy Instrument Sales Share by Manufacturers in 2022

    Figure 21. Global Stereotactic-guided Biopsy Instrument Revenue Share by Manufacturers in 2022

    Figure 22. The Global 5 and 10 Largest Stereotactic-guided Biopsy Instrument Players: Market Share by Revenue in 2022

    Figure 23. Stereotactic-guided Biopsy Instrument Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 24. Global Stereotactic-guided Biopsy Instrument Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 25. North America Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2018-2029)

    Figure 26. North America Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2018-2029)

    Figure 27. U.S. Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. Canada Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. Europe Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2018-2029)

    Figure 30. Europe Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2018-2029)

    Figure 31. Germany Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. France Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. U.K. Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Italy Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Russia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Asia Pacific Stereotactic-guided Biopsy Instrument Sales Market Share by Region (2018-2029)

    Figure 37. Asia Pacific Stereotactic-guided Biopsy Instrument Revenue Market Share by Region (2018-2029)

    Figure 38. China Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Japan Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. South Korea Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. India Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Australia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Taiwan Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Indonesia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Thailand Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Malaysia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Philippines Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Latin America Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2018-2029)

    Figure 49. Latin America Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2018-2029)

    Figure 50. Mexico Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Brazil Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Argentina Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Middle East & Africa Stereotactic-guided Biopsy Instrument Sales Market Share by Country (2018-2029)

    Figure 54. Middle East & Africa Stereotactic-guided Biopsy Instrument Revenue Market Share by Country (2018-2029)

    Figure 55. Turkey Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 56. Saudi Arabia Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 57. UAE Stereotactic-guided Biopsy Instrument Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 58. Global Sales Market Share of Stereotactic-guided Biopsy Instrument by Type (2018-2029)

    Figure 59. Global Revenue Market Share of Stereotactic-guided Biopsy Instrument by Type (2018-2029)

    Figure 60. Global Stereotactic-guided Biopsy Instrument Price (USD/Unit) by Type (2018-2029)

    Figure 61. Global Sales Market Share of Stereotactic-guided Biopsy Instrument by Application (2018-2029)

    Figure 62. Global Revenue Market Share of Stereotactic-guided Biopsy Instrument by Application (2018-2029)

    Figure 63. Global Stereotactic-guided Biopsy Instrument Price (USD/Unit) by Application (2018-2029)

    Figure 64. Stereotactic-guided Biopsy Instrument Value Chain

    Figure 65. Stereotactic-guided Biopsy Instrument Production Process

    Figure 66. Channels of Distribution (Direct Vs Distribution)

    Figure 67. Distributors Profiles

    Figure 68. Bottom-up and Top-down Approaches for This Report

    Figure 69. Data Triangulation

    Figure 70. Key Executives Interviewed